LOSTWITHIEL SURGERY — All Prescriptions & Medications — Page 3
Practice Code: L82039 | LOSTWITHIEL, PL22 0EF
Showing results 101-150 of 560
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ascorbic acid | 306 | 11.7K | £19.2K | +1,390.3% ▲ |
| Memantine hydrochloride | 292 | 6,938 | £1.1K | -11.6% ▼ |
| 290 | 573 | £20.4K | -46.8% ▼ | |
| Tadalafil | 286 | 5,292 | £3.6K | +68.2% ▲ |
| Ferrous sulfate | 286 | 12.2K | £417 | -44.4% ▼ |
| Mometasone furoate | 286 | 301 | £2.3K | -28.8% ▼ |
| Clobetasone butyrate | 285 | 11.1K | £4.2K | +39.6% ▲ |
| 283 | 283 | £11.9K | -8.9% ▼ | |
| Lithium carbonate | 280 | 9,654 | £1.4K | +120.7% ▲ |
| Desogestrel | 280 | 24.2K | £870 | -29.4% ▼ |
| Baclofen | 277 | 40.9K | £653 | +38.3% ▲ |
| Esomeprazole | 270 | 10.5K | £791 | -33.3% ▼ |
| Dulaglutide | 269 | 1,075 | £19.0K | +134.7% ▲ |
| Sildenafil (Erectile Dysfunction) | 269 | 3,648 | £518 | -46.6% ▼ |
| Estradiol with progestogen | 268 | 11.7K | £7.0K | -21.4% ▼ |
| Paroxetine hydrochloride | 265 | 9,679 | £457 | +42.0% ▲ |
| Combined ethinylestradiol 30mcg | 264 | 17.9K | £1.7K | -5.0% ▼ |
| Hydrocortisone | 263 | 8,305 | £2.0K | -41.3% ▼ |
| Prochlorperazine maleate | 261 | 13.2K | £927 | +29.1% ▲ |
| Methotrexate | 256 | 5,256 | £4.5K | -21.3% ▼ |
| Risperidone | 254 | 11.7K | £6.2K | +0.4% vs avg |
| Mirabegron | 249 | 7,342 | £6.6K | -38.0% ▼ |
| Carbocisteine | 247 | 33.6K | £823 | -53.7% ▼ |
| 247 | 1,403 | £342 | +2,710.0% ▲ | |
| Nebivolol | 242 | 5,586 | £1.9K | +128.3% ▲ |
| Hyoscine butylbromide | 240 | 25.4K | £1.7K | +3.0% ▲ |
| Olanzapine | 240 | 7,014 | £665 | -35.2% ▼ |
| Tirzepatide | 240 | 259 | £23.7K | +23.6% ▲ |
| Pioglitazone hydrochloride | 238 | 6,244 | £441 | +169.1% ▲ |
| Thiamine hydrochloride | 238 | 12.0K | £324 | -54.9% ▼ |
| Donepezil hydrochloride | 235 | 5,656 | £225 | -23.8% ▼ |
| Sodium valproate | 229 | 23.6K | £2.7K | -28.0% ▼ |
| Lidocaine hydrochloride | 227 | 2,115 | £2.1K | +31.6% ▲ |
| Buprenorphine | 226 | 6,320 | £3.9K | -38.3% ▼ |
| Timolol and bimatoprost | 211 | 2,694 | £2.9K | +39.0% ▲ |
| Trimethoprim | 210 | 4,835 | £292 | +2.8% ▲ |
| 208 | 1,428 | £578 | +103.6% ▲ | |
| Fluticasone propionate (Nasal) | 203 | 1,133 | £2.3K | +39.4% ▲ |
| Hydroxychloroquine sulfate | 202 | 8,198 | £577 | +4.3% ▲ |
| Lercanidipine hydrochloride | 200 | 7,644 | £788 | -67.6% ▼ |
| Etoricoxib | 200 | 6,398 | £1.6K | +148.2% ▲ |
| 195 | 1,795 | £880 | -21.8% ▼ | |
| Anastrozole | 192 | 5,544 | £212 | +110.9% ▲ |
| 192 | 24.1K | £953 | -59.5% ▼ | |
| Quetiapine | 190 | 6,636 | £2.9K | -69.5% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 190 | 27.8K | £1.7K | +25.7% ▲ |
| Oxybutynin | 190 | 10.5K | £1.1K | -0.3% vs avg |
| 189 | 14.2K | £1.3K | -12.6% ▼ | |
| 188 | 82.9K | £1.2K | -28.7% ▼ | |
| Insulin aspart | 187 | 1,517 | £8.8K | -50.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.